| 今开：1.34 | 昨收：1.34 |
| 最高：1.38 | 最低：1.3 |
| 涨停价： | 跌停价： |
| 总市值：8.0711453E7 |
Passage Bio(PASG)03-20 04:15
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008495 Size: 5 KB 网页链接查看全文
Passage Bio(PASG)04-09 18:05
$Passage Bio(PASG)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-044912 Act: 34 Size: 3 MB 网页链接查看全文
Passage Bio(PASG)03-01 05:15
$Passage Bio(PASG)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-029361 Act: 34 Size: 201 KB 网页链接查看全文
Passage Bio(PASG)02-14 08:45
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-003637 Size: 15 KB 网页链接查看全文
Passage Bio(PASG)03-04 20:05
$Passage Bio(PASG)$ 8-K Current report, items 2.02, 5.02, 7.01, and 9.01 Accession Number: 0001558370-24-002309 Act: 34 Size: 6 MB 网页链接查看全文
Passage Bio(PASG)03-20 04:15
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008489 Size: 5 KB 网页链接查看全文
Passage Bio(PASG)03-20 04:15
$Passage Bio(PASG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-008491 Size: 5 KB 网页链接查看全文
Passage Bio(PASG)04-13 05:45
$Passage Bio(PASG)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000947871-24-000373 Act: 34 Size: 114 KB 网页链接查看全文
Passage Bio(PASG)04-17 18:05
$Passage Bio(PASG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000982 Act: 33 Size: 1 KB 网页链接查看全文
Passage Bio(PASG)04-09 18:05
$Passage Bio(PASG)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-044915 Act: 34 Size: 1 MB 网页链接查看全文
Replix锐璞美股2021-04-05 19:19
$Passage Bio(PASG)$ Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease
$Moderna(MRNA)$ $百济神州(BGNE)$查看全文
Replix锐璞美股2021-03-03 20:20
$Passage Bio(PASG)$ $PASG$ Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
- On track to initiate three Phase 1/2 clinical programs in the first half of 2021: PBGM01 for GM1 gangliosidosis (GM1), PBFT02 for frontotemporal dementi...查看全文
医药魔方2021-01-21 21:41
2020年1月，基因疗法开发商Generation Bio完成了1.1亿美元的C轮融资用以推进其A型血友病和苯丙酮尿症治疗药物的开发；5个月后，Generation又进行了首次公开募股（IPO），募资2.3亿美元。这无疑是一个迹象，表明投资者对下一代治疗罕见疾病的基因疗法非常感兴趣。
去年一年，尽管面临着各种挑战...查看全文
Replix锐璞美股2020-08-29 13:01
$Iovance(IOVA)$ 看看未来会发生什么。$Passage Bio(PASG)$ $CRISPR Therapeutics(CRSP)$查看全文
chuminhua2020-05-08 16:18
5/7，Passage Bio$Passage Bio(PASG)$ 与美国宾夕法尼亚大学去年达成合作，获得5款基因疗法，以及7个基因疗法的选择权。现在两家公司扩展了合作，增加了5个新项目，总计达到17个。合作期限也从2022年延长至2025年。作为回报，每年将向该大学提供500万美元。查看全文
chuminhua2020-02-28 23:21
2/27，Passage Bio$Passage Bio(PASG)$ 在Nasdaq IPO，发行价为18美元，共募集了2.16亿美元，比最初计划多72%。该公司聚焦基因疗法，与Frazier和OrbiMed合作，致力于开发罕见CNS单基因疾病的疗法。交易代码为$ PASG。查看全文
$Passage Bio(PASG)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-21-002688 Act: 34 Size: 8 MB 网页链接
$Passage Bio(PASG)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-20-137129 Act: 34 Size: 435 KB 网页链接
$Passage Bio(PASG)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-20-013472 Act: 34 Size: 5 MB 网页链接
$Passage Bio(PASG)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-20-013468 Act: 34 Size: 214 KB 网页链接
$Passage Bio(PASG)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-20-103244 Act: 34 Size: 3 MB 网页链接
$Passage Bio(PASG)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-20-010495 Act: 34 Size: 4 MB 网页链接
$Passage Bio(PASG)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-20-094318 Act: 34 Size: 107 KB 网页链接
$Passage Bio(PASG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-20-001577 Act: 34 Size: 8 KB 网页链接
$Passage Bio(PASG)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-20-006239 Act: 34 Size: 6 MB 网页链接
$Passage Bio(PASG)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-20-059108 Act: 34 Size: 99 KB 网页链接